Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study

Chunyan Lu,1 Yun Chen,2 Bin Zhang,2 Yu Chen,2 Fan Bai,2 Decai Chen1 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China; 2Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China Abstract: Teriparatide is the first anabolic agent for osteoporosis, and t...

Full description

Bibliographic Details
Main Authors: Lu C, Chen Y, Zhang B, Bai F, Chen D
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:Clinical Interventions in Aging
Subjects:
Osteoporosis Teriparatide Lumbar spine bone mineral density Osteocalcin
Online Access:https://www.dovepress.com/response-to-teriparatide-in-chinese-patients-with-established-osteopor-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/response-to-teriparatide-in-chinese-patients-with-established-osteopor-peer-reviewed-article-CIA

Similar Items